Gaballah Kamis, Hassan Mawada
Department of Oral and Craniofacial Health Sciences, College of Dental Medicine, University of Sharjah, United Arab Emirates.
College of Dentistry, Ajman University, Ajman, United Arab Emirates.
Eur J Dent. 2022 Oct;16(4):775-780. doi: 10.1055/s-0041-1739436. Epub 2022 Jan 11.
In this article, we explored the level of knowledge and practice of licensed dentists in the United Arab Emirates regarding managing patients on antithrombotic medications. Moreover, to assess the need for educational intervention in this area is one of the objectives.
A total of 502 dentists answered 22 close-ended questionnaires. The sample size was determined based on the registry of the Ministry of Health.
Only 5.6 and 5.9% showed satisfactory overall awareness about aspirin and plavix, respectively, as drugs may hamper hemostasis. A substantial proportion of dentists consider aspirin (63.1%) and clopidogrel (52.2%) discontinuation before treatment. More than one-third of the participants shall not consider extracting teeth before physician approval, and one-quarter to one-third of them refer patients on such medications to oral surgeons to perform tooth extraction. Most respondents did not adequately answer the questions about the additional hemostatic measures and postoperative analgesia. A significantly high number of participants ( = 440, 87.6%) want to attend updated courses on the dental management of such patients.
The dentists demonstrate a contrasting diversity of knowledge and practice approaches to patient management on antiplatelet agents. There is an apparent demand to raise understanding of the evidence-based management of a patient on such medications. It is vital to keep formalized training sessions and provide the necessary expertise to students and dentists to prevent unwanted complications.
在本文中,我们探讨了阿拉伯联合酋长国执业牙医在管理服用抗血栓药物患者方面的知识水平和实践情况。此外,评估该领域教育干预的必要性也是目标之一。
共有502名牙医回答了22份封闭式问卷。样本量是根据卫生部登记册确定的。
分别只有5.6%和5.9%的人对阿司匹林和波立维作为可能妨碍止血的药物表现出令人满意的总体认知。相当一部分牙医认为在治疗前停用阿司匹林(63.1%)和氯吡格雷(52.2%)。超过三分之一的参与者在未经医生批准前不会考虑拔牙,其中四分之一到三分之一的人会将服用此类药物的患者转介给口腔外科医生进行拔牙。大多数受访者没有充分回答关于额外止血措施和术后镇痛的问题。大量参与者(n = 440,87.6%)希望参加关于此类患者牙科管理的最新课程。
牙医在抗血小板药物患者管理的知识和实践方法上表现出明显的差异。显然需要提高对此类药物患者循证管理的认识。持续开展正规培训课程并为学生和牙医提供必要的专业知识以预防不良并发症至关重要。